GGrantIndex
Sort

64,565 grants matching drug discovery

Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer

$854,530
Vincent Sandanayaka · Nirogyone Therapeutics, Llc · R44 · FY2021 · CA

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$854,077
James E. Heubi · University Of Cincinnati · UL1 · FY2010 · RR

Closing the Gaps on Buruli Ulcer Diagnosis, Treatment, and Prevention

$853,989
Eric L Nuermberger · Johns Hopkins University · R01 · FY2020 · AI

Developing RNA therapeutics for rare neurodevelopmental disorders

$853,987
Francesco Lotti · Dayi Therapeutics, Inc. · R42 · FY2025 · HD

Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis

$853,963
Gregory Paul Downey · National Jewish Health · UG3 · FY2018 · TR

Using Omics to Understand the Effects of Drug Abuse on HIV Latent Reservoir

$853,917
Eric O Johnson · Research Triangle Institute · R61 · FY2020 · DA

Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia

$853,822
Joseph D. Buxbaum · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · MH

Fluorescent IRE Sensor for Synucleinopathy Drug Discovery

$853,817
Wen Shen · Lucerna, Inc. · R44 · FY2022 · NS

Design And Development Of Experimental Therapeutics

$853,810
Nigel H. Greig · National Institute On Aging · ZIA · FY2020 · AG

LTQ Orbitrap Velos

$853,719
Larry L David · Oregon Health & Science University · S10 · FY2012 · OD

Advancing method benchmarking and data sharing through crowd-sourced competitions in cancer research

$853,709
Justin Guinney · Sage Bionetworks · U24 · FY2020 · CA

Biological annotation of TCGA data

$853,708
Gordon B. Mills · University Of Tx Md Anderson Can Ctr · U01 · FY2013 · CA

Multimodal Qdot Probes for Bioimaging of Cells and Tumors in Small Animals

$853,641
Shimon Weiss · University Of California Los Angeles · R01 · FY2009 · EB

Epigenetic HIV Silencing in Macrophages

$853,363
Ronald G Collman · University Of Pennsylvania · R61 · FY2019 · AI

Structural Analysis and Inhibitor Optimization of Cryptosporidium n-myristoyltransferase for Drug Discovery

$852,908
Bart Lee Staker · Seattle Children'S Hospital · R01 · FY2024 · AI

Understanding Mechanisms and Sex-Differences in Visceral Pain

$852,896
Holly A. Ingraham · University Of California, San Francisco · R01 · FY2025 · DK

Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2

$852,747
Jeffrey R Johnson · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI

The integrated stress response in cognitive disorders

$852,716
Paul Pfaffinger · Baylor College Of Medicine · R01 · FY2024 · NS

Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates

$852,523
Jon Clardy · Harvard Medical School · U19 · FY2015 · TW

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

$852,400
Suresh S Ramalingam · Emory University · UG1 · FY2019 · CA

Therapeutic Development of Osteogenic Oxysterol, Oxy133, for Spine Fusion

$852,387
Farhad Parhami · Max Biopharma, Inc. · R44 · FY2022 · AR

The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model

$852,370
Peter W Kalivas · Medical University Of South Carolina · U01 · FY2020 · DA

Experimental Therapeutics of Anti-Cancer Agents with Phase I Emphasis

$852,262
Michael R Grever · Ohio State University · UM1 · FY2014 · CA

Exploring how the genome folds through proximity ligation and sequencing

$852,201
Erez Lieberman-Aiden · Baylor College Of Medicine · DP2 · FY2011 · OD

Cincinnati Cooperative Center of Excellence in Hematology

$852,127
Yi Zheng · Cincinnati Childrens Hosp Med Ctr · U54 · FY2024 · DK